Last reviewed · How we verify
NCT06594354
Oral Cryotherapy Applied to Patients Undergoing Chemotherapy
NA trial testing ICE in Oncologic Disease in 65 participants. Completed in 1 June 2025.
20 October 2024
Quick facts
| Lead sponsor | Karadeniz Technical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 65 |
| Start date | 1 July 2024 |
| Primary completion | 20 October 2024 |
| Estimated completion | 1 June 2025 |
| Sites | 3 locations across Turkey (Türkiye) |
Drugs / interventions tested
- ICE — full drug profile →
Conditions studied
- Oncologic Disease — all drugs for Oncologic Disease →
- Cancer — all drugs for Cancer →
- Chemotherapy — all drugs for Chemotherapy →
Sponsor
Karadeniz Technical University
Who can join
18 and older, any sex, with Oncologic Disease or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Taste alteration can cause problems such as loss of appetite, inadequate energy intake and weight loss in oncology patients, increasing the risk of malnutrition and negatively affecting the quality of life of patients. It is thought that other problems mentioned can be prevented and quality of life can be improved with effective management of taste alteration. This study was planned as a randomized controlled, pre-test-post-test and experimental design to determine the effect of oral cryotherapy application on chemotherapy-induced taste alteration, thus on appetite level, malnutrition risk and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06594354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ICE
Trials testing the same drug.
- NCT05464329 — Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B · Phase 1 · active not recruiting
- NCT05466266 — Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiography in Pat · NA · unknown
- NCT01453205 — A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-C · Phase 2 · completed
Other recruiting trials for Oncologic Disease
Currently open trials in the same condition.
- NCT07435597 — Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients · NA · recruiting
- NCT07294040 — Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients · recruiting
- NCT07481994 — Changes in Value-Based Assessment in Patients Undergoing Major Oncological Surgery · active not recruiting
- NCT06304194 — Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology · NA · recruiting
Other Karadeniz Technical University trials
Trials by the same sponsor.
- NCT07526779 — Motivational Interviewing on Loneliness Level, Activities of Daily Living, and Quality of Life in Elderly · NA · not yet recruiting
- NCT07448168 — Effect of Standardized Patient Simulation on Nursing Students' Assessment, Diagnosis Skills, and Experiences · NA · not yet recruiting
- NCT07435233 — Different Reality Simulation Education Methods on Nursing Students · NA · active not recruiting
- NCT07238348 — Analgesic Effectiveness of SPSIPB Versus Thoracic Epidural and Systemic Opioid Analgesia After VATS (SPSIPB-VATS) · not yet recruiting
- NCT07297498 — The Effect of Simulation-based Education Within the Framework of the Clinical Judgment Model on Nursing Students' Clinic · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06594354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karadeniz Technical University
- Last refreshed: 19 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing